Grifols has been granted a patent for a device that handles syringes and an automated device for preparing intravenous medication. The device includes a cap support, a device for removing the cap and needle from the syringe, and a device for closing the syringe using a closed system transfer device or a cap. The invention also includes a support for the closed system transfer device or cap, as well as a set, system, and method for handling syringes and two automated devices for preparing intravenous medication. GlobalData’s report on Grifols gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Grifols, Attenuated virus-based vaccines was a key innovation area identified from patents. Grifols's grant share as of September 2023 was 51%. Grant share is based on the ratio of number of grants to total number of patents.
Device for handling and preparing intravenous medication with syringe
A recently granted patent (Publication Number: US11738155B2) describes a device for handling a syringe. The device includes a main body with various components for efficient and safe syringe handling.
One key feature of the device is a cap support that securely holds the cap of the needle during removal and insertion. The cap support includes a housing designed to dimensionally interfere with the cap, ensuring a secure fit. Additionally, the cap support may have a secondary slot perpendicular to the housing, which can receive a flange of the cap.
The device also includes a mechanism for joint removal of the cap and needle from the syringe. This mechanism has the ability to rotate around a longitudinal axis and is connected to the main body through a resilient element. The mechanism includes a slot with two parallel faces that interfere dimensionally with the cap of the syringe, facilitating the removal process.
Furthermore, the device features at least one device for closing the syringe using a closed system transfer device (CSTD) or a cap. This device includes a projection for fixing a support for the CSTD or cap, with the support being replaceable. The support has a recess matching the shape of the projection and a housing for the CSTD or cap.
Other notable features of the device include a sensor in the cap support for detecting the presence of the cap, a sensor for verifying the removal of the needle and cap from the syringe, and a sensor for verifying the presence of the cap or CSTD on the syringe.
The patent also describes a support for the CSTD or cap, which can be used with the device. The support includes a body with two parts connected by resilient elements. The first part has a recess matching the shape of the projection of the device for closing the syringe, while the second part has a housing for the CSTD or cap.
The patent further mentions a set comprising the device and at least one support for the CSTD or cap, as well as a system for handling a syringe. The system includes the device and a robotic arm capable of handling the syringe during various processes, such as needle removal and closure with a CSTD or cap.
Additionally, the patent covers an automated device for preparing intravenous medication, which can incorporate the described device for efficient and safe handling of syringes.
Overall, this patented device offers improved functionality and safety in handling syringes, particularly in medical settings.
To know more about GlobalData’s detailed insights on Grifols, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
